Inflammatory Bowel Disease Confers a Lower Risk of Colorectal Cancer to Females Than to Males

Gastroenterology

Volumn 138, Issue 5, 2010, Pages

  Söderlund, Sverre ^a   Granath, Fredrik ^b   Broström, Olle ^a   Karlén, Per ^a   Löfberg, Robert ^b,c   Ekbom, Anders ^b   Askling, Johan ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c IBD Unit   (Sweden)

Author keywords

Colorectal Cancer; Inflammatory Bowel Disease; Sex Differences

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; ULCERATIVE COLITIS;

EID: 77951691568     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.02.007     Document Type: Article

References (40)

1. Virchow R. Die krankhaften geschwulste (1863), August Hirschwald, Berlin
2. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
3. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
4. Rutter M., Saunders B., Wilkinson K., et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126 (2004) 451-459
5. Levi F., La Vecchia C., Lucchini F., et al. Trends in cancer mortality sex ratios in Europe, 1950-1989. World Health Stat Q 45 (1992) 117-164
6. Naugler W.E., Sakurai T., Kim S., et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317 (2007) 121-124
7. Rakoff-Nahoum S., and Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317 (2007) 124-127
8. Soderlund S., Brandt L., Lapidus A., et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology 136 (2009) 1561-1567
9. Swedish National Board of Health and Welfare (Socialstyrelsen). Statistical Databases - Cause of Death Statistics. http://www.socialstyrelsen.se/uppfoljning/statistik/statistikdatabas Accessed March 16, 2010
10. Ekbom A., Helmick C., Zack M., et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 100 (1991) 350-358
11. Lapidus A., Bernell O., Hellers G., et al. Incidence of Crohn's disease in Stockholm County 1955-1989. Gut 41 (1997) 480-486
12. Lofberg R., Brostrom O., Karlen P., et al. Colonoscopic surveillance in long-standing total ulcerative colitis-a 15-year follow-up study. Gastroenterology 99 (1990) 1021-1031
13. Persson P.G., Bernell O., Leijonmarck C.E., et al. Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology 110 (1996) 1339-1345
14. Nordenvall B., Brostrom O., Berglund M., et al. Incidence of ulcerative colitis in Stockholm County 1955-1979. Scand J Gastroenterol 20 (1985) 783-790
15. Winther K.V., Jess T., Langholz E., et al. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2 (2004) 1088-1095
16. Bernstein C.N., Blanchard J.F., Kliewer E., et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91 (2001) 854-862
17. Persson P.G., Karlen P., Bernell O., et al. Crohn's disease and cancer: a population-based cohort study. Gastroenterology 107 (1994) 1675-1679
18. Munkholm P., Langholz E., Davidsen M., et al. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 105 (1993) 1716-1723
19. Ekbom A., Helmick C., Zack M., et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 336 (1990) 357-359
20. Karlen P., Lofberg R., Brostrom O., et al. Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol 94 (1999) 1047-1052
21. Ekbom A., Helmick C., Zack M., et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323 (1990) 1228-1233
22. Pinczowski D., Ekbom A., Baron J., et al. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 107 (1994) 117-120
23. Moody G.A., Jayanthi V., Probert C.S., et al. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 8 (1996) 1179-1183
24. Eaden J., Abrams K., Ekbom A., et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 14 (2000) 145-153
25. Statistics Sweden. Statistics Sweden Web site. http://www.scb.se/ Accessed December 16, 2009
26. Kane S.V., Cohen R.D., Aikens J.E., et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 96 (2001) 2929-2933
27. Sewitch M.J., Abrahamowicz M., Barkun A., et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 98 (2003) 1535-1544
28. Ediger J.P., Walker J.R., Graff L., et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol 102 (2007) 1417-1426
29. Grodstein F., Newcomb P.A., and Stampfer M.J. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 106 (1999) 574-582
30. Jacobsen B.K., Vollset S.E., and Kvale G. Do reproductive factors influence colorectal cancer survival?. J Clin Epidemiol 48 (1995) 1119-1122
31. Potter J.D., Bostick R.M., Grandits G.A., et al. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study. Cancer Epidemiol Biomarkers Prev 5 (1996) 779-784
32. Chlebowski R.T., Wactawski-Wende J., Ritenbaugh C., et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 350 (2004) 991-1004
33. Issa J.P., Ottaviano Y.L., Celano P., et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7 (1994) 536-540
34. Slattery M.L., Potter J.D., Curtin K., et al. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 61 (2001) 126-130
35. Fujiwara I., Yashiro M., Kubo N., et al. Ulcerative colitis-associated colorectal cancer is frequently associated with the microsatellite instability pathway. Dis Colon Rectum 51 (2008) 1387-1394
36. Allison J., Herrinton L.J., Liu L., et al. Natural history of severe ulcerative colitis in a community-based health plan. Clin Gastroenterol Hepatol 6 (2008) 999-1003
37. Wagtmans M.J., Verspaget H.W., Lamers C.B., et al. Gender-related differences in the clinical course of Crohn's disease. Am J Gastroenterol 96 (2001) 1541-1546
38. Cosnes J., Carbonnel F., Carrat F., et al. Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut 45 (1999) 218-222
39. Kane S.V., and Reddy D. Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. Am J Gastroenterol 103 (2008) 1193-1196
40. Jess T., Loftus Jr. E.V., Velayos F.S., et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology 130 (2006) 1039-1046